Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR.

Am J Surg Pathol. 2005 Jun;29(6):734-46.

PMID:
15897740
2.

Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.

Wells CA, Sloane JP, Coleman D, Munt C, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Connolly CE, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Reiner A, Saksela E, Sigal-Zafrani B, Sylvan M, Borisch B, Cserni G, Decker T, Kerner H, Kulka J, Regitnig P, Sapino A, Tanous AM, Thorstenson S, Zozaya E; European Working Group for Breast Screening Pathology.

Virchows Arch. 2004 Aug;445(2):119-28. Epub 2004 Jun 24.

PMID:
15221370
3.

Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.

Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W; UK MRI Breast Screening Study Advisory Group.

Breast. 2000 Apr;9(2):78-82.

PMID:
14731703
4.

Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.

Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W; UK MRI Breast Screening Study Advisory Group.

Breast. 2000 Apr;9(2):72-7.

PMID:
14731702
5.

Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast.

Teo NB, Shoker BS, Jarvis C, Sloane JP, Holcombe C.

J Clin Pathol. 2003 Dec;56(12):919-23.

6.

Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast.

Teo NB, Shoker BS, Jarvis C, Martin L, Sloane JP, Holcombe C.

Eur J Cancer. 2003 Jan;39(1):38-44.

PMID:
12504656
7.

Angiogenesis in pre-invasive cancers.

Teo NB, Shoker BS, Martin L, Sloane JP, Holcombe C.

Anticancer Res. 2002 Jul-Aug;22(4):2061-72. Review.

PMID:
12174884
8.

Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years.

Anderson TJ, Sufi F, Ellis IO, Sloane JP, Moss S.

Hum Pathol. 2002 Mar;33(3):365-71.

PMID:
11979379
9.

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast.

Teo NB, Shoker BS, Jarvis C, Martin L, Sloane JP, Holcombe C.

Br J Cancer. 2002 Mar 18;86(6):905-11.

10.

Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study.

Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EM, Foster CS.

Am J Surg Pathol. 2002 Apr;26(4):421-30.

PMID:
11914619
11.

Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.

Shaaban AM, Sloane JP, West CR, Foster CS.

Am J Pathol. 2002 Feb;160(2):597-604.

12.

Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.

Shoker BS, Jarvis C, Davies MP, Iqbal M, Sibson DR, Sloane JP.

Br J Cancer. 2001 Apr 20;84(8):1064-9.

13.

Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells.

Iqbal M, Davies MP, Shoker BS, Jarvis C, Sibson DR, Sloane JP.

J Pathol. 2001 Mar;193(3):333-8.

PMID:
11241412
14.

Abnormal regulation of the oestrogen receptor in benign breast lesions.

Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MP, Sibson DR, Sloane JP.

J Clin Pathol. 2000 Oct;53(10):778-83.

15.

Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Graves M, Hayes C, Jenkins JP, Jones AP, Keevil SF, Leach MO, Liney GP, Moss SM, Padhani AR, Parker GJ, Pointon LJ, Ponder BA, Redpath TW, Sloane JP, Turnbull LW, Walker LG, Warren RM.

Magn Reson Imaging. 2000 Sep;18(7):765-76.

PMID:
11027869
16.

Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.

Elston CW, Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Dervan P, Drijkoningen M, Eusebi V, Faverly D, Holland R, Jacquemier J, Lacerda M, Martinez-Penuela J, de Miguel C, Mossi S, Munt C, Peterse JL, Rank F, Reiner A, Sylvan M, Wells CA, Zafrani B.

Eur J Cancer. 2000 Sep;36(14):1769-72.

PMID:
10974624
17.

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.

Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Futreal PA, Peto J, Stoppa-Lyonnet D, Bignon YJ, Stratton MR.

Clin Cancer Res. 2000 Mar;6(3):782-9.

18.

Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MP, Sibson DR, Sloane JP.

Am J Pathol. 1999 Dec;155(6):1811-5.

19.

DCIS grading schemes and clinical implications.

Shoker BS, Sloane JP.

Histopathology. 1999 Nov;35(5):393-400. Review.

PMID:
10583553
20.

Oestrogen receptor expression in the normal and pre-cancerous breast.

Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP.

J Pathol. 1999 Jul;188(3):237-44.

PMID:
10419589
21.

Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.

Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Eusebi V, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B.

Virchows Arch. 1999 Jan;434(1):3-10.

PMID:
10071228
22.

The fourth EORTC DCIS Consensus meeting (Château Marquette, Heemskerk, The Netherlands, 23-24 January 1998)--conference report.

Recht A, Rutgers EJ, Fentiman IS, Kurtz JM, Mansel RE, Sloane JP.

Eur J Cancer. 1998 Oct;34(11):1664-9. Review. No abstract available.

PMID:
9893649
23.

Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.

Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Dervan P, Eusebi V, De Miguel C, Drijkoningen M, Elston CW, Faverley D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B.

Hum Pathol. 1998 Oct;29(10):1056-62.

PMID:
9781641
24.

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.

Badve S, A'Hern RP, Ward AM, Millis RR, Pinder SE, Ellis IO, Gusterson BA, Sloane JP.

Hum Pathol. 1998 Sep;29(9):915-23.

PMID:
9744307
25.

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Chang-Claude J, Sobol H, Weber B, Stratton MR, Easton DF.

J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45.

PMID:
9701363
26.

[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].

Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Böcker W, Bussolati G, Connolly CE, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Holland R, Jacquemier J, Lacerda M, Lindgren A, Martinez-Peñuela J, Peterse JL, Rank F, Tsakraklides V, de Wolf C, Zafrani B.

Pathologe. 1997 Jan;18(1):71-88. German. No abstract available.

PMID:
9157408
27.

Terminology for carcinoma-in-situ of the breast.

Sloane JP, Lakhani SR, Stratton MR.

Lancet. 1996 May 4;347(9010):1259-60. No abstract available.

PMID:
8622469
28.

Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.

Vinnicombe SJ, MacVicar AD, Guy RL, Sloane JP, Powles TJ, Knee G, Husband JE.

Radiology. 1996 Feb;198(2):333-40.

PMID:
8596827
29.

Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations.

Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP.

Lab Invest. 1996 Jan;74(1):129-35.

PMID:
8569175
30.
31.

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast.

De Potter CR, Schelfhout AM, Verbeeck P, Lakhani SR, Brünken R, Schroeter CA, Van den Tweel JG, Schauer AJ, Sloane JP.

Hum Pathol. 1995 Jun;26(6):601-6.

PMID:
7774888
32.

Molecules and micrometastases.

Sloane JP.

Lancet. 1995 May 20;345(8960):1255-6. No abstract available.

PMID:
7746053
33.

Pseudoangiomatous hyperplasia of male breast.

Badve S, Sloane JP.

Histopathology. 1995 May;26(5):463-6.

PMID:
7544764
34.

Loss of heterozygosity in lobular carcinoma in situ of the breast.

Lakhani SR, Collins N, Sloane JP, Stratton MR.

Clin Mol Pathol. 1995 Apr;48(2):M74-8.

35.

Loss of heterozygosity in ductal carcinoma in situ of the breast.

Stratton MR, Collins N, Lakhani SR, Sloane JP.

J Pathol. 1995 Feb;175(2):195-201.

PMID:
7738715
36.

Malignant myoepithelioma (myoepithelial carcinoma) of the breast: a detailed cytokeratin study.

Lakhani SR, O'Hare MJ, Monaghan P, Winehouse J, Gazet JC, Sloane JP.

J Clin Pathol. 1995 Feb;48(2):164-7.

37.

Intravascular malignant lymphomatosis (angiotropic large-cell lymphoma). A case report with evidence for T-cell lineage with polymerase chain reaction analysis.

Lakhani SR, Hulman G, Hall JM, Slack DN, Sloane JP.

Histopathology. 1994 Sep;25(3):283-6. No abstract available.

PMID:
7821899
39.

Borderline lesions detected by breast screening.

Sloane JP.

Br J Surg. 1994 Apr;81(4):481-3. No abstract available.

PMID:
8205418
40.

Peripheral blood involvement in non-Hodgkin's lymphoma detected by clonal gene rearrangement as a biological prognostic marker.

Hiorns LR, Nicholls J, Sloane JP, Horwich A, Ashley S, Brada M.

Br J Cancer. 1994 Feb;69(2):347-51.

41.

The polymerase chain reaction in diagnosing lymphoid disorders.

McCarthy KP, Slack DN, Sloane JP.

Mol Biol Rep. 1994 Jan;19(1):69-77. Review.

PMID:
8170468
42.

Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.

Sloane JP, Ellman R, Anderson TJ, Brown CL, Coyne J, Dallimore NS, Davies JD, Eakins D, Ellis IO, Elston CW, et al.

Eur J Cancer. 1994;30A(10):1414-9.

PMID:
7833094
44.

Evidence for premalignant lesions in the human breast.

Sloane JP.

Eur J Cancer Prev. 1993 Nov;2 Suppl 3:17-21. Review. No abstract available.

PMID:
8298446
45.
46.
47.
48.

Cytokine gene expression in skin and lymphoid organs in graft versus host disease.

Rowbottom AW, Norton J, Riches PG, Hobbs JR, Powles RL, Sloane JP.

J Clin Pathol. 1993 Apr;46(4):341-5.

49.

The pathology of bone marrow transplantation.

Sloane JP, Norton J.

Histopathology. 1993 Mar;22(3):201-9. Review.

PMID:
8495953

Supplemental Content

Loading ...
Support Center